Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MYNZ will decline by -31.44% over the next 2 Weeks and hit $0.48 by Tuesday, March 31, 2026. In that time frame, MYNZ's share price is expected to range between $0.31 and $0.65.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 31, 2026 | 0.28 | 0.43 | 0.61 |
| Mar 30, 2026 | 0.28 | 0.46 | 0.63 |
| Mar 27, 2026 | 0.29 | 0.46 | 0.62 |
| Mar 26, 2026 | 0.25 | 0.42 | 0.60 |
| Mar 25, 2026 | 0.28 | 0.46 | 0.63 |
| Mar 24, 2026 | 0.33 | 0.51 | 0.69 |
| Mar 23, 2026 | 0.37 | 0.54 | 0.70 |
| Mar 20, 2026 | 0.37 | 0.54 | 0.71 |
| Mar 19, 2026 | 0.33 | 0.50 | 0.65 |
| Mar 18, 2026 | 0.36 | 0.53 | 0.69 |
MYNZ shares rose +0.84% in Friday, May 22, 2026's trading session, rising from a previous close of $3.56 to move at $3.59. The stock demonstrated notable intraday movement (see MYNZ's key stats for a full breakdown), fluctuating between $3.38 and $3.72, a +10.06% trading range. While recent weeks have seen some volatility, MYNZ has managed to secure a +372.37% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 3.49M shares changing hands, 3.26M more than the previous session. This amounted to $12.52M in total market activity.
Will MYNZ Continue Its Downward Trend?
According to analyst ratings and projections for MYNZ, Mainz Biomed B.V. shares are anticipated to decrease by -490.67%, potentially reaching $0.61 per share by March 31, 2026. Short-term technical indicators for MYNZ currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the MYNZ stock forecast, now is not the best time to buy MYNZ stock because its current trading price is +736.05% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MYNZ covering social and institutional perspectives.
MYNZ Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MYNZ's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.14% to 48.36%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 40.96%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 42.35%, maintains a neutral outlook for the long term. Insights into MYNZ's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Mainz Biomed BV Short-Term Forecasts
MYNZ Forecast For Next 5 Days
Our algorithm anticipates Mainz Biomed BV (MYNZ) stock could hit $0.57 by Mar 27, 2026. This represents a -84.10% fall from today's price, following a -5.98% change over the past five days.
MYNZ Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Mainz Biomed B.V. (MYNZ) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.47, which would mean a -86.91% decrease from the current price of $3.59. Projections for this period range from a high of $0.72 to a low of $0.21.
MYNZ Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Mainz Biomed BV's price over the next three months point to a drop. MYNZ stock is expected to peak at $2.63 on Jul 09, 2026 before potentially dipping to $0.00 on Aug 21, 2026. On average, MYNZ is likely to trade around $0.23 in the coming 90 days.
Mainz Biomed BV Stock Forecast 2025
Based on our predictive models, Mainz Biomed BV (MYNZ) is expected to trade between $0.00 and $2.84 throughout 2026. This would result in an average price of $0.23, potentially offering investors a -93.59% return from current levels.
Mainz Biomed B.V. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Mainz Biomed B.V. (MYNZ) is positioned to show a strong performance in March 2026. The price is predicted to move between $0.00 and $2.55, settling at an average of $0.47. This could translate to a -86.91% loss.
April 2026
Based on current market signals, Mainz Biomed B.V. is projected to trend april 2026. We forecast a trading range from $0.00 to $2.84, with a likely average price of $0.45. Investors could expect a potential return of -87.47%.
May 2026
Our predictive algorithms indicate Mainz Biomed B.V. stock may see a shift in May 2026. The expected range spans $0.00–$2.56, with an average target of $0.32. This represents a cautious outlook and a possible loss of -91.09%.
June 2026
Analyzing established trends, Mainz Biomed B.V. looks set to move in June 2026. Projections place the stock between $0.00 and $2.62, averaging around $0.27. This suggests a -92.48% loss from current levels.
July 2026
Market indicators suggest Mainz Biomed B.V. could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $2.63, with a midpoint forecast of $0.25. The stock might deliver a -93.04% loss.
August 2026
Forecasting for August 2026, models estimate that Mainz Biomed B.V. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.35, averaging $0.15. This signals a cautious trajectory with potential returns around -95.82%.
September 2026
According to our latest forecast models, Mainz Biomed B.V. (MYNZ) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $2.56, settling at an average of $0.22. This could translate to a -93.87% loss.
October 2026
Based on current market signals, Mainz Biomed B.V. is projected to trend october 2026. We forecast a trading range from $0.00 to $2.27, with a likely average price of $0.14. Investors could expect a potential return of -96.10%.
November 2026
Our predictive algorithms indicate Mainz Biomed B.V. stock may see a shift in November 2026. The expected range spans $0.00–$2.41, with an average target of $0.10. This represents a cautious outlook and a possible loss of -97.21%.
December 2026
Analyzing established trends, Mainz Biomed B.V. looks set to move in December 2026. Projections place the stock between $0.00 and $2.36, averaging around $0.07. This suggests a -98.05% loss from current levels.
January 2027
Market indicators suggest Mainz Biomed B.V. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $2.35, with a midpoint forecast of $0.06. The stock might deliver a -98.33% loss.
February 2027
Forecasting for February 2027, models estimate that Mainz Biomed B.V. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.48, averaging $0.07. This signals a cautious trajectory with potential returns around -98.05%.
March 2027
According to our latest forecast models, Mainz Biomed B.V. (MYNZ) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $2.45, settling at an average of $0.06. This could translate to a -98.33% loss.
MYNZ's history of dividends and stock splits also plays a role in long-term investor confidence.

